Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VRDN
VRDN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VRDN News
Viridian Therapeutics Shares Drop 31% Despite Positive Trial Results
19h ago
NASDAQ.COM
Viridian Therapeutics Stock Plummets 35.3% Following Release of Late-Stage Trial Results for Thyroid Eye Disease Treatment
20h ago
moomoo
Mixed Close for US Stocks as Nasdaq Hits 7.75-Month Low Amid Middle East Tensions
10h ago
NASDAQ.COM
Viridian Therapeutics Shares Plunge 32% Following Phase 3 Trial Results for Elegrobart
12h ago
seekingalpha
US Stock Market Declines Amid Rising Oil Prices
13h ago
NASDAQ.COM
Mixed U.S. Stock Indices Amid Rising Oil Prices
14h ago
NASDAQ.COM
US Stocks Rise as Oil Prices Hit Three-Week High
16h ago
NASDAQ.COM
Middle East Tensions Impact Global Markets
17h ago
NASDAQ.COM
Viridian Therapeutics Shares Plunge 41% After Phase 3 Trial Results
21h ago
stocktwits
Viridian Reports Positive Data from Elegrobart Clinical Trial
22h ago
Newsfilter
Kynam Capital Reduces Stake in Viridian Therapeutics
Mar 21 2026
Fool
Kynam Capital Reduces Stake in Viridian Therapeutics
Mar 21 2026
NASDAQ.COM
Kynam Capital Management Cuts Viridian Stake by Over $81 Million
Mar 21 2026
Yahoo Finance
VR Adviser, LLC Reduces Stake in Ocular Therapeutix
Mar 18 2026
Fool
VR Adviser, LLC Sells Shares of Ocular Therapeutix
Mar 18 2026
NASDAQ.COM
VR Adviser Increases Stake in Savara by Over 1 Million Shares
Mar 15 2026
NASDAQ.COM
Show More News
